diabetestalk.net

Medtronic Mri Surescan Pacemaker Cost

Evaluating Mri-compatible Pacemakers

Evaluating Mri-compatible Pacemakers

Patient Data Now Paves the Way to Widespread Clinical Application? Luca Santini M.D., Ph.D; Giovanni B. Forleo M.D., Ph.D; Massimo Santini M.D Currently Available MRI-conditional Devices New pacing systems have recently been specifically designed by the major companies for safe use in the MRI environment (EnRhythm, Advisa, and Revo MRI SureScan pacemakers and CapSureFix MRI leads, Medtronic, Inc., Minneapolis, MN, USA; Accent MRI pacemaker and Tendril MRI leads, St. Jude Medical Inc., Sylmar, CA, USA; ProMRI Pacing Systems Evia pacemaker series and Solia and Safio pacing leads, BIOTRONIK SE & Co. KG, Berlin, Germany) ( Table II ). However, now only the Medtronic Revo system has obtained FDA approval, while the other products have Conformit Europenne (CE) marks and currently Advisa MRI, Accent MRI, and Evia Pro MRI are available in Europe. In order to make the systems "MRI-conditional," components have been redesigned to minimize the energy induced and discharged that is caused by the static, gradient, and combined field effects. New features, especially with regard to lead design and geometry, characterize the system. Specifically Medtronic redesigned: The circuit protection normally applied to the power supply. The leads, to minimize and attenuate RF energy discharge at the tip. The firmware to provide MRI-conditional protection. The change of reed-switch to a Hall sensor. Furthermore, it has developed simple programming with clear steps to provide predictable pacemaker performance during the scan, should it be required, and the system components that are MRI-conditional have been clearly identified. In the first experience reported with this new system, a direct safety and efficacy comparison was made between the Medtronic Enrhythm MRI compatible system with conventi Continue reading >>

New Wave Of Mri-safe Pacemakers Set To Ship To Hospitals

New Wave Of Mri-safe Pacemakers Set To Ship To Hospitals

New wave of MRI-safe pacemakers set to ship to hospitals This week Medtronic will begin shipping to hospitals in the United States the first pacemaker approved by the FDA as safe for most MRI scans. For consumers, it is a significant step in what is expected to be a wave of new MRI-compatible implanted cardiac devices. But this is an example of one technology chasing another and the one being chased, the MRI scanner, is changing and is a step ahead of the new line of pacemakers. The pacemaker approved for U.S. distribution is Medtronic's first-generation pacemaker with certain limitations, while its second-generation MRI-compatible pacemaker is already in use in Europe where approval for medical devices is not as demanding as it is in the U.S. So lets check out what this is all about -- what it means now for current and future heart patients and where it may be headed. We are all born with a natural pacemaker that directs our heart to beat 60 to 100 times a minute at rest. The pacemaker is a little mass of muscle fibers the size and shape of an almond known medically as the sinoatrial node located in the right atrium, one of four chambers of the heart. The natural pacemaker can last a lifetime. Or it can become defective. And even if it keeps working normally, some point may not function well along the electrical pathway from the pacemaker to the hearts ventricles which contract to force blood out to the body. Millions of people in the world whose hearts beat too fast, too slow, or out of sync because their own pacemaker is not able to do the job right, follow their doctors recommendation to get an artificial pacemaker connected to their heart to direct its beating. The battery-run pacemaker in a titanium or titanium alloy case the size of a small cell phone, (why cant Continue reading >>

Medicare To Pay For Mris In Patients With Pacemakers

Medicare To Pay For Mris In Patients With Pacemakers

Medicare to Pay for MRIs in Patients With Pacemakers by Chris Kaiser Chris Kaiser, Cardiology Editor, MedPage Today WASHINGTON -- The Centers for Medicare & Medicaid Services (CMS) has determined that the evidence is strong enough to reimburse for MRI exams in Medicare patients who have permanent pacemakers. "We propose to change the language ... of the NCD Manual to remove the contraindication for Medicare coverage of MRI in beneficiaries with implanted PMs [permanent pacemakers] when the PMs are used according to the FDA-approved labeling for use in an MRI environment," the agency's proposed decision memorandum states. The FDA approved the first MRI-conditional pacemaker (Medtronic Revo MRI SureScan Pacing System) on Feb. 8, but CMS specifically noted that the change in payment policy "does not include any coverage determination about the Medtronic Revo MRI SureScan Pacing System itself or any other pacemaker." The proposed coverage is not limited to any specific disease or condition. The new decision broadens one announced on Feb. 24, when CMS said it would cover MRI exams only for patients with pacemakers if they were enrolled in approved clinical studies of MRI. The next day, CMS received a request letter from Medtronic referencing the randomized controlled trial of 464 pacemaker patients demonstrating the safety of the device in the MR environment and provided CMS with a reference to the journal in which the study was published. "The requester asked that CMS remove completely the contraindication in the MRI policy for patients with pacemaker devices that have been approved by the FDA for use in the MR environment," according to the CMS decision memorandum. Following a 30-day public comment period regarding coverage of MRI scans in patients with pacemakers, CMS co Continue reading >>

Heart Patients With Pacemakers Can Now Undergo Mri

Heart Patients With Pacemakers Can Now Undergo Mri

Heart patients with pacemakers can now undergo MRI Heart patients with pacemakers can now undergo MRI A cardiac patient with a pacemaker implanted inside his chest can now finally undergo an MRI scan. The world's first MRI-compatible pacemaker has now been used on Indian patients. NEW DELHI: A cardiac patient with a pacemaker implanted inside his chest can now finally undergo an MRI scan. The world's first MRI-compatible pacemaker has now been used on Indian patients. Four hospitals in India Max (New Delhi), Apollo (Madurai), B M Birla (Kolkata) and SGPGI (Lucknow) have successfully implanted the MRI-compatible pacemaker on cardiac patients over the last two weeks. Until now, patients with a pacemaker three million living in the world at present are barred from undergoing MRI scans. What's worse, one in every two such patients requires an MRI -- the imaging technology of choice for neurological (brain), musculoskeletal, cardiovascular and oncological (cancer) imaging sometime in their life. Unfortunately, current pacemaker designs include a metal wire that connects the pacemaker to the heart. During an MRI, the wire can get hot, seriously affecting blood vessels, scarring the heart, and potentially inducing a rapid heart condition, which can prove fatal. The wire also picks up radio frequency interference, which can impair the pacemaker's performance. "The MRI-compatible pacemaker called EnRhythm MRI SureScan Pacing system will be a boon for all patients with a pacemaker, especially those who are old. They usually require an MRI for several conditions, the most common being for abdomen and brain imaging. But till now, they could not undergo an MRI scan for their entire life," Dr Praveen Chandra, cardiologist from Max Hospital told TOI. He added: "It is absolutely safe Continue reading >>

Medtronic's Advisa Mri Surescan Pacemaker Finally Cleared In U.s. | Medgadget

Medtronic's Advisa Mri Surescan Pacemaker Finally Cleared In U.s. | Medgadget

31mayalldayalldayMedTech Conference, 2018Minneapolis, MN, USA The Medtech Conference is an Unparalleled Gathering of the Leading Innovators, Investors and Executives from around the Nation Discussing the Timeliest Issues and Opportunities. The Medtech Conference is an Unparalleled Gathering of the Leading Innovators, Investors and Executives from around the Nation Discussing the Timeliest Issues and Opportunities. In its 17th year, the Medtech Conference, formerly known as the Medtech Investing Conference, will bring together investors, executives, and entrepreneurs from across the US and around the world. The tightly packed, daylong event centers on the primary forces that make medtech work. Panels will cover critical issues facing start-ups including valuations, financing, business models, reimbursement, and exit opportunities. To learn more about the program or to register, please visit 04junallday05allday3rd Edition of International Conference on Applied CrystallographyLondon, UK Euroscicon invites all the participants from all over the world to attend "3rd edition of International conference on Applied Crystallography" Euroscicon invites all the participants from all over the world to attend 3rd edition of International conference on Applied Crystallography during Jun 04-05, 2018, London, UK. Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Crystallography 2018 provides a perfect symposium for scientists, engineers, directors of companies and students in the field of Materials science to meet and share their knowledge. The theme of conference is Crystallography of today is the innovation of tomorrow. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward ma Continue reading >>

Fda Approves First And Only Mri-safe Pacemaker

Fda Approves First And Only Mri-safe Pacemaker

FDA approves first and only MRI-safe pacemaker Medtronic's Revo MRI SureScan is designed for use during magnetic resonance imaging. The company says it will begin shipping the $5,000 to $10,000 devices immediately. Pacemaker patients who opt for magnetic resonance imaging risk serious complications, including damage to the pacemaker's parts or a change in the device's ability to consistently trigger a heartbeat (called pacing capture threshold). That is, until now. The U.S. Food and Drug Administration has just approved Medtronic's Revo MRI SureScan pacemaker for use in the U.S.; in doing so, the SureScan has become the first and only pacemaker in the country approved as MR-Conditional. Minneapolis-based Medtronic says it will begin shipping the pacing system--which costs between $5,000 and $10,000--immediately. "[This] is a major technological breakthrough for patients who need access to MRI," says Rod Gimbel of Cardiology Associates of East Tennessee in Knoxville, Tenn., in a news release . "Providing pacemaker patients with access to MRI allows detection and treatment of serious medical conditions such as stroke, cancer, and a wide variety of important neurologic and orthopedic conditions." Because MRI scanners can cause pacemakers to misinterpret MRI-generated electrical noise and withhold (or delivery unnecessary) pacing therapy, the Revo includes "SureScan" technology that sets the device into MRI mode, with hardware modifications to both the device and the leads that reduce hazards produced by MRIs. Since Medtronic's pacemakers are designed "to treat bradycardia (a slow, irregular, or interrupted heartbeat)," pacemaker patients tend to be a population that could benefit from MRI scans. Medtronic estimates that some 200,000 pacemaker patients in the U.S. who coul Continue reading >>

Ep Vantage - Therapeutic Focus Us Market For Mri-compatible Pacemakers Grows

Ep Vantage - Therapeutic Focus Us Market For Mri-compatible Pacemakers Grows

Therapeutic focus US market for MRI-compatible pacemakers grows With the FDA approval of Medtronic s second-generation MRI-friendly pacemaker, the market is finally maturing. The Advisa DR MRI SureScan builds on the same companys Revo device, which got the nod two years ago. It is considered unsafe for patients with standard pacemakers to undergo MRI imaging as the strong magnetic field in the scanners can cause the devices to malfunction. The majority of pacemaker recipients are likely to require an MRI scan at some point, and with the population ageing, demand will grow. Medtronic has the US market to itself for now, but the pivotal trial of St Jude Medicals Accent MRI device is due to read out in March next year, and then things could start moving very quickly. The Advisa is an advance on the Revo, Medtronic says, because it has improved battery life and higher upper tracking rates, which allow faster heart rates for when people exercise. More than 100,000 Revo devices have been sold worldwide, the Minnesota company says, and it estimates that more than 10% of patients implanted with it have received MRIs. The Revo is priced at between $5,000 and $10,000 apiece, with the cost of the surgical procedure on top. Sales of MRI-compatible pacemakers hinge on reimbursement, not of the devices themselves although Revo is covered but of the MRI scans. The Centres for Medicare and Medicaid Services has long refused Medicare coverage for MRI imaging of patients with pacemakers. However, in July 2011 it decided to allow the procedure when the pacemakers are used according to the FDA-approved labelling for use in an MRI environment. This is a huge argument in favour of the use of MRI-compatible pacemakers. St Jude Medical will probably be Medtronic s first challenger in the US. Continue reading >>

Memorial Implants Mri-safe Medtronic Pacemaker

Memorial Implants Mri-safe Medtronic Pacemaker

Memorial implants MRI-safe Medtronic pacemaker [caption id="attachment_31225" align="alignleft" width="324" caption="Dr. Peter Chang-Sing"][/caption] SANTA ROSA -- Santa Rosa Memorial Hospital last week implanted an MRI-safe pacemaker into a patient, making it the first hospital north of the Golden Gate Bridge to do so, according to the hospital and the medical device maker. Minneapolis-based Medtronic, whose cardiovascular division is based in Santa Rosa, created the Revo MRI SureScan pacing system, which the company said is the only pacemaker in the country designed for use in an MRI environment. The new technology allows pacemaker patients to safely undergo a fairly common procedure that is typically bypassed because of potential complications, "For many of our patients, as medicine advances and they live longer, they're going to need an MRI to diagnose health-related problems," said Dr. Peter Chang-Sing, the implanting physician and medical director for Electrophysiology Services at Memorial's Heart and Vascular Institute. "Now we have a device which allows these patients to take advantage of the MRI's diagnostic capabilities and its lower risk of radiation exposure compared to others imaging tests." An estimated 200,000 pacemaker recipients in the U.S. must forgo MRI scans due to "serious complications" that can arise when the cardiac device is subjected to the powerful magnetic field used in MRIs, or magnetic resonance imaging, according to Medtronic. Patients with traditional pacemakers are exposed to significant risks when undergoing MRIs, including unintended cardiac stimulation, overheating of the pacemaker's leads and resulting injury to the patient's heart, and a malfunctioning pacemaker, the level II trauma center said in announcing the implementation. Med Continue reading >>

Medtronic Wins Ce Mark For Mri-safe Leads

Medtronic Wins Ce Mark For Mri-safe Leads

Home Medtronic wins CE Mark for MRI-safe leads Medtronic wins CE Mark for MRI-safe leads Medtronic (NYSE: MDT ) won CE Mark approval in the European Union for its latest-generation MRI-friendly pacemaker lead set, the CapSure Sense MRI SureScan. The leads are the smallest available in the world that allow patients to undergo MRI procedures without risking damage to their devices from the scanners powerful magnets. Medtronic was 1st to bring an MRI-friendly pacemaker to the U.S. market when it won an FDA green light for the Revo MRI SureScan pacemaker and its leads in February 2011. The new CapSure leads use a "passive" fixation system, as opposed to the "active" fixation used with the previous generation of Revo leads. "Active leads use something within the lead to attach them; usually its a screw where the lead is actually attached to the heart by screwing a small screw into the heart muscle," Dr. David Steinhouse, vice president & medical director of Medtronics CRDM division, told MassDevice.com. "Passive fixation leads have what are called tines in them; its a little bit like a barb or arrow, where it gets stuck in the heart as opposed to being screwed in the heart." The new leads "allow physicians who are used to using passive fixation leads to be able to implant and still be MRI-compatible," Steinhouse added. Medtronic CEO Omar Ishrak credited the Revo system with adding 4 points of share gainin the U.S. pacing market to its 3rd quarter earnings . "Our U.S. pacing business grew 8%, driven by the ongoing success of our Revo MRI SureScan pacemaker," Ishrak said during a conference call with analysts. "Revo continues to command a mid-teens percentage price uplift, which is offsetting pricing pressure in the pacing market." The Fridley, Minn.-bas Continue reading >>

Magnetic Resonance Imaging-conditional Devices: Luxury Or Real Clinical Need? - Sciencedirect

Magnetic Resonance Imaging-conditional Devices: Luxury Or Real Clinical Need? - Sciencedirect

Magnetic resonance imaging-conditional devices: Luxury or real clinical need? Author links open overlay panel Sophie I.Mavrogeni Open Access funded by Hellenic Cardiological Society Although the risk of MRI scanning on patients with conventional devices is lower than initially thought, the patient's safety can only be guaranteed when using MRI-conditional devices. The most important modifications in MRI-conditional devices include a) Reduction in ferromagnetic components to reduce magnetic attraction and susceptibility artifacts; b) Replacement of the reed switch by a Hall sensor in order to avoid unpredictable reed switch behavior; c) Lead coil design to minimize lead heating and electrical current induction; d) Filter circuitry to prevent damage to the internal power supply; and e) Dedicated pacemaker programming to prevent inappropriate pacemaker inhibition and competing rhythms. Although many companies claim to have MRI-conditional devices, adoption in clinical practice is limited because a) Not all companies have MRI-conditional devices approved for both 1.5 and 3T; b) Not all companies offer the option of unlimited MRI scanning (without an exclusion zone in the thorax); c) Certain companies allow only a 30-min MRI scanning and only in afebrile patients; and d) Despite having MRI-conditional pacemakers, certain companies do not have MRI-conditional defibrillators and CRT systems. It is clear that this new technology opens the door for MRI to a growing number of patients; however, the widespread adoption of MRI-conditional devices will depend on real-life issues, such as cost,clinical indications for such a device and the permanent education of health care professionals. Continue reading >>

Mri-conditional Pacemakers: Current Perspectives

Mri-conditional Pacemakers: Current Perspectives

MRI-conditional pacemakers: current perspectives 1Cardiology Department, Hospital da Luz, Lisbon, Portugal 2Cardiology Department, Hospital Santa Cruz-CHLO, Lisbon, Portugal 1Cardiology Department, Hospital da Luz, Lisbon, Portugal 2Cardiology Department, Hospital Santa Cruz-CHLO, Lisbon, Portugal 1Cardiology Department, Hospital da Luz, Lisbon, Portugal 2Cardiology Department, Hospital Santa Cruz-CHLO, Lisbon, Portugal 3Radiology Department, Hospital da Luz, Lisbon, Portugal Correspondence: Antnio M Ferreira, Hospital da Luz, Avenida Lusada 100, 1500-650 Lisbon, Portugal, Tel +351 21 710 4400, Fax +351 21 710 4409, Email [email protected] Author information Copyright and License information Disclaimer Copyright 2014 Ferreira et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution Non Commercial (unported, v3.0) License The full terms of the License are available at . Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. This article has been cited by other articles in PMC. Use of both magnetic resonance imaging (MRI) and pacing devices has undergone remarkable growth in recent years, and it is estimated that the majority of patients with pacemakers will need an MRI during their lifetime. These investigations will generally be denied due to the potentially dangerous interactions between cardiac devices and the magnetic fields and radio frequency energy used in MRI. Despite the increasing reports of uneventful scanning in selected patients with conventional pacemakers under close surveillance, MRI is still contraindicated in those circumstances and cannot be considered a routine procedure. These limitation Continue reading >>

Who Should Get An Mri-compatible Pacemaker?

Who Should Get An Mri-compatible Pacemaker?

Who Should Get An MRI-Compatible Pacemaker? The Medtronic Revo MRI SureScan pacemaker is out, and the natural question arises: who should get it? Up until now, pacemakers have not coexisted well with MRI scanners. Problems including inductive heating of the leads, spurious reprogramming, and various malfunctions have been reported. Up until now, patients getting pacemakers have been told that they could not ever get MRI scans, and thats that. Now that there is an MRI compatible pacemaker, should all new pacemaker candidates get one? Im sure Medtronic would be happy if the answer to this question is yes. The new pacemaker and leads are more expensive than their other pacemakers, and, given the ugly morass that is the U.S. Patent Office, where a company like Microsoft can patent double-clicking with a mouse, Im sure Medtronic holds a bunch of patents on MRI compatible pacemakers that will suppress any healthy competition from other companies, or at least result in hefty licensing fees that other companies will pass on to the consumer. So the cost will stay high, though I doubt this kind of pacemaker is any more difficult to make than any other pacemaker. So the question becomes: is it worth the added cost of this pacing system just to ensure that sometime in the future a patient may be able to get an MRI scan? I might add that, in addition to the added cost, the system uses larger caliber leads, and the Revo generator has an upper tracking rate of only 150 bpm, making it less attractive for use in younger patients who might be more likely to need an MRI scan over the course of their lifetime. Medtronic states on their website that 75% of pacemaker patients will have an indication for an MRI scan during the lifetime of their device. I think this statistic needs to be take Continue reading >>

Medtronic's Advisa, Ensura Pacemakers Win Ce Mark

Medtronic's Advisa, Ensura Pacemakers Win Ce Mark

Medtronic's Advisa, Ensura Pacemakers Win CE Mark Medtronic, Inc. ( MDT ) recently reported the receipt of CE (Conformit Europenne) Mark and the subsequent commercial launch of its Advisa and Ensura SR MRI SureScan single chamber pacemaker devices in Europe. However, the news had no significant impact on Medtronic's share price which remained essentially unchanged at $61.02 at market close on Monday. Magnetic resonance imaging, or MRI, is the standard procedure in soft tissue imaging. It provides information that cannot be otherwise seen through X-ray, ultrasound or CT scan, and refrains from exposing patients to ionizing radiation. Advisa and Ensura SR MRI pacemakers provide single chamber pacing engineered with the same SureScan technology used in other Medtronic MR-Conditional pacemakers and implantable cardioverter-defibrillators (ICDs). Additional features include improved diagnostic information and storage as well as a 35% improvement in battery longevity. Both the pacemakers have been approved for MRI scans positioned on any region of the human body. However, these devices are yet to be sanctioned for use in the U.S. Prior to the approval of MR-conditional pacemakers, patients implanted with the Advisa and Ensura devices were not allowed to undergo MRI procedures because of the risk of harmful interaction between the devices and the MRI scanner. Roughly 50-75% of the patients with an implanted pacemaker are estimated to be in the need of an MRI scan over the lifetime of their device. Reliable sources suggest that for patients with chronic atrial fibrillation and intermittent AV block, physicians can administer better treatment options to those implanted with Advisa or Ensura MRI single chamber pacemakers. Single-chamber pacemaker patients in Europe will now have Continue reading >>

Mri Conditional Pacemakers: The Future Begins Here

Mri Conditional Pacemakers: The Future Begins Here

MRI Conditional Pacemakers: The Future Begins Here Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN ABSTRACT. Cardiac rhythm management is evolving at a rapid pace. Advances in pacemaker technology continue to improve the quality of life for our patients, allowing us to diagnose and treat them more efficiently than ever before. With the release of the first US Food and Drug Administration labeled magnetic resonance imaging (MRI) conditional pacemaker, more patients will have access to the diagnostic capabilities of MRI. We will review current studies that demonstrate the safe use of MRI in pacemaker patients. We will also report on our own experience with these patients. KEYWORDS. cardiac rhythm management device, impedance, magnetic resonance imaging, pacemaker, generator. Dr. Clair has received honoraria for lectures from Medtronic and Boston Scientific as well as research support from Medtronic, Biotronik and St Jude Medical. Ms. Sabin reports no conflict of interest for the published content. Manuscript received November 30, 2011, final version accepted December 27, 2011. Address correspondence to: Walter K. Clair, MD, MPH, Vanderbilt Heart and Vascular Institute, Vanderbilt University Medical Center, 1215 21st Avenue South, 5th Floor MCE-North Tower, Suite 5209, Nashville, TN 37232-8802. E-mail: [email protected] Over the last half century, the practice of medicine has been enhanced by technological developments in both the diagnosis and the treatment of patients with cardiovascular diseases. The evolution of implantable pacemakers in the middle of the twentieth century 1 and the placement of the first implantable cardioverter-defibrillator (ICD) in 1980 2 have significantly improved the quality and length of life Continue reading >>

Medtronic Pacemaker Works With Mris

Medtronic Pacemaker Works With Mris

St. Paul police-scanner Facebook group aims for safety but is it changing crime perceptions? Heart doctors are cheering news that Fridley-based Medtronic is moving closer to marketing the first MRI-compatible pacemaker in the U.S. But they dont yet predict a dramatic shift in business away from Medtronics cross-town rivals Little Canada-based St. Jude Medical and Natick, Mass.-based Boston Scientific, which makes pacemakers in Arden Hills. I think its an advantage for Medtronic, said Dr. Robert Hauser, a cardiologist at Abbott Northwestern Hospital in Minneapolis. (But) there are multiple factors that physicians must weigh in selecting a pacemaker for a particular patient. Earlier this month, a committee of outside experts unanimously recommended that the Food and Drug Administration approve Medtronics experimental device, which goes by the name Revo MRI SureScan Pacing System. Pacemaker patients are told to avoid MRI scans for safety reasons. Doctors are concerned that pacemaker components could become dangerously hot during an MRI or that devices could stop functioning due to interference from the MRI signal. The new Revo MRI device includes special hardware and leads that are designed to reduce or eliminate problems, Medtronic said. I think its a huge development, said Dr. Uma Valeti, an interventional cardiologist at the St. Paul Heart Clinic. Valeti said he and colleagues see pacemaker patients every day who could benefit from MRI scans but dont undergo them because of the risk. Despite the large patient need, Valeti said he didnt expect heart doctors would shift all their patients to the Revo MRI if the FDA approves it. Thats because the MRI-compatible device is an entry-level pacemaker that lacks monitoring features doctors often want for patients, Valeti said. Continue reading >>

More in diabetes